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have non-pharmacological benefits for the prevention
and treatment of many potential side effects from
chemotherapy. This includes the whole spectrum of
cancer care from diagnosis through treatment and long-
term survivorship. The case report by Korn et al that
accompanies this editorial describes an adolescent
leukemia survivor with anthracycline-induced cardiomy-
opathy who was able to train and compete in a triathlon.
This is an important contribution that demonstrates to
an extreme the physical capabilities of cancer survivors.
The role of exercise in the prevention and treatment
of anthracycline cardiotoxicity remains controversial. In
animal models, beneficial effects of exercise include
preservation of left ventricular systolic and diastolic
function by modulating heart rate and contractility
through (a) an increase in antioxidant activity with re-
duction of reactive oxygen species release and increase
in heat shock proteins; (b) a decrease in proapoptotic
signaling; (c) a decrease in myocyte turnover through
suppression of proapoptotic protein synthesis; and (d)
changes in energy metabolism [1]. In humans, the data
aremore limited. However, a case series of five long-
term survivors of childhood cancer with subclinical
anthracycline-induced cardiomyopathy demonstrated
feasibility of a 12-week home aerobic and strength
training program, and similar to the case report by
Korn et al, survivors showed an improvement in exer-
cise capacity and cardiopulmonary fitness (VO2 and O2
pulse). Importantly, these survivors were 25–30 years
from cancer diagnosis and treatment completion, had
an LVEF 40–50% at baseline, and did not experience
any cardiac events or complications over the 12-week
exercise program [2].
In the patient not exposed to potentially cardiotoxic
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heart – training and participation in “extreme” activities
(marathons, triathlons) can increase pre-load and induce
atrial and ventricular volume overload with liberation of
cardiac troponins, and with continued training, may
induce structural changes – patchy areas of myocar-
dial fibrosis, LV dilatation/hypertrophy and increase
in myocardial mass [3].
This leads to a word of caution related to the intensity
of exercise described in this case report. Vigorous activity
with potential acute increases in catecholamines and in-
creased energy demands can increase the risk of sudden
death and acute myocardial infarction, especially in pa-
tients with underlying structural heart disease [4]. Patients
with prior anthracycline exposure may have latent mito-
chondrial and myocardial dysfunction that reduces cardiac
reserve and could magnify that risk, and additionally, the
stress of exercise without adequate reserve may lead to
clinical decomposition and overt heart failure.
Risk of sudden cardiac death has also been described
in cancer survivors with cancer therapy-related cardiac
dysfunction. In the general population, sudden cardiac
death in young athletes <35 years of age is typically due to
inherited conditions (structural pathology, arrhythmias)
and in older athletes >35 years of age is typically due to
coronary artery disease (CAD) [5]. Childhood cancer sur-
vivors are at risk for both – structural cardiomyopathy
from direct toxic effects of chemotherapy or radiation
therapy, as well as accelerated CAD, particularly if they
received concurrent radiation therapy to the left chest
in addition to cardiotoxic chemotherapy. The role for
screening exercise testing in long-term childhood can-
cer survivors is not well delineated, but may be an im-
portant consideration before embarking on an intense
exercise training program. In a study of screening echo-
cardiography for more than 1800 adult survivors of
childhood cancer treated with anthracycline chemo-
therapy (+/- radiation to the left chest), asymptomatic
CAD was found in 69 patients (3.8%) and newlyle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Smith and Carver Cardio-Oncology  (2017) 3:3 Page 2 of 2identified (not previously diagnosed) in 40 patients
(2.2%), and valvular regurgitation or stenosis was found
in 488 patients (28%), newly identified in 414 patients
(23.8%) [6]. In pilot studies, screening CT coronary
angiography has identified clinically significant CAD re-
quiring percutaneous or surgical revascularization in
asymptomatic survivors of Hodgkin lymphoma exposed
to mediastinal radiation therapy; larger studies are needed
to determine the utility of this approach for identifying
CAD in cancer survivors at high risk [7–10].
The lack of consensus in the guidelines for exercise in-
tensity among cancer survivors at high risk of cardiovas-
cular late effects reflects the paucity of clinical studies in
this area. The International Late Effects of Childhood
Cancer Guideline Harmonization Group recommends
cardiology consultation for cancer survivors with known
therapy-related cardiomyopathy and for cancer survivors
at high risk of cardiomyopathy prior to initiation of
high-intensity exercise [11]. The American College of
Sports Medicine recommends medical evaluation for
adult cancer survivors with known cardiac conditions,
whether treatment-related or not, to determine safe ex-
ercise limits before beginning an exercise program, but
does not specifically advocate for assessment of asymp-
tomatic survivors not known to have cardiac disease
[12]. A study of adult cancer survivors who underwent
cardiopulmonary exercise testing suggested that traditional
American College of Sports Medicine cardiac risk stratifi-
cation – which does not account for anthracycline or radi-
ation therapy exposure – did not adequately describe
exercise risk in this population of cancer survivors [13].
What is the answer? Maintaining balance and moder-
ation is critical. A “little exercise” is good; “excessive
exercise” may be detrimental. Therefore, our practice is
to discourage extreme levels of exercise but recommend
low-intensity endurance training and activities. Before
prescribing a vigorous exercise program in patients pre-
viously exposed to anthracycline-based chemotherapy or
radiation therapy to the left chest, patients should have:
1- Thorough screening history and physical exam that
includes a current assessment of cardiac structure
and function (echocardiogram and possibly
cardiopulmonary exercise testing);
2- Education about possible warning “red-flag” symptoms;
3- Prescription for graded training with avoidance of
high-risk activities, especially in the absence of
adequate pre-training;
4- General recommendations about healthy lifestyle;
5- Regular supervision and follow-up with medical
personnel
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